Maya Jeitany

1.1k total citations · 1 hit paper
11 papers, 550 citations indexed

About

Maya Jeitany is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Maya Jeitany has authored 11 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Physiology and 2 papers in Oncology. Recurrent topics in Maya Jeitany's work include Telomeres, Telomerase, and Senescence (5 papers), DNA Repair Mechanisms (3 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Maya Jeitany is often cited by papers focused on Telomeres, Telomerase, and Senescence (5 papers), DNA Repair Mechanisms (3 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Maya Jeitany collaborates with scholars based in Singapore, France and United States. Maya Jeitany's co-authors include François D. Boussin, José Ramón Pineda, Neil J. Ganem, Cyril H. Benes, Daniel A. Haber, Alysia R. Bryll, Francesca Bersani, Lee Zou, Hiroaki Wakimoto and Mario L. Suvà and has published in prestigious journals such as Science, Nature Communications and International Journal of Cancer.

In The Last Decade

Maya Jeitany

10 papers receiving 546 citations

Hit Papers

Alternative lengthening of telomeres renders cancer cells... 2015 2026 2018 2022 2015 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors
    2015 376 citations Rachel Litman Flynn, Maya Jeitany et al. Science profile →

Peers

Maya Jeitany
Aino Murtomäki United States
Coralie Hoareau‐Aveilla France
Basem S. Goueli United States
Esther van de Kamp Netherlands
Ruban Mangadu United States
Ana Angulo‐Urarte Spain
Ryan Ward Canada
Stéphanie Courtois-Cox France
Laura Dupont Belgium
Antonio Díaz‐López Spain
Aino Murtomäki United States
Maya Jeitany
Citations per year, relative to Maya Jeitany Maya Jeitany (= 1×) peers Aino Murtomäki

Countries citing papers authored by Maya Jeitany

Since Specialization
Citations

This map shows the geographic impact of Maya Jeitany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maya Jeitany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maya Jeitany more than expected).

Fields of papers citing papers by Maya Jeitany

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maya Jeitany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maya Jeitany. The network helps show where Maya Jeitany may publish in the future.

Co-authorship network of co-authors of Maya Jeitany

This figure shows the co-authorship network connecting the top 25 collaborators of Maya Jeitany. A scholar is included among the top collaborators of Maya Jeitany based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maya Jeitany. Maya Jeitany is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Lim, Kah Wai, et al.. (2025). Targeting FANCM by antisense oligonucleotides in ALT-positive cancers. Molecular Therapy — Nucleic Acids. 36(2). 102492–102492. 2 indexed citations
2.
3.
Dakle, Pushkar, Elina Pathak, Vikas Madan, et al.. (2023). Signalling inhibition by ponatinib disrupts productive alternative lengthening of telomeres (ALT). Nature Communications. 14(1). 1919–1919. 12 indexed citations
4.
Madan, Vikas, Pushkar Dakle, Lin Han, et al.. (2021). ZRSR1 co-operates with ZRSR2 in regulating splicing of U12-type introns in murine hematopoietic cells. Haematologica. 107(3). 680–689. 12 indexed citations
5.
Jeitany, Maya, Pushkar Dakle, Elina Pathak, et al.. (2020). Novel carfilzomib-based combinations as potential therapeutic strategies for liposarcomas. Cellular and Molecular Life Sciences. 78(4). 1837–1851. 12 indexed citations
6.
Desmaze, Chantal, Maya Jeitany, Laurent Gauthier, et al.. (2019). ALT cancer cells are specifically sensitive to lysine acetyl transferase inhibition. Oncotarget. 10(7). 773–784. 6 indexed citations
7.
Jeitany, Maya, Cédric Leroy, M. Lafitte, et al.. (2018). Inhibition of DDR 1‐ BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer. EMBO Molecular Medicine. 10(4). 90 indexed citations
8.
Jeitany, Maya, José Ramón Pineda, Nicolas Ugolin, et al.. (2017). Opposite effects of GCN5 and PCAF knockdowns on the alternative mechanism of telomere maintenance. Oncotarget. 8(16). 26269–26280. 9 indexed citations
9.
Pineda, José Ramón, et al.. (2017). Intranasal Administration of Temozolomide Delayed the Development of Brain Tumors Initiated by Human Glioma Stem-Like Cell in Nude Mice. Journal of Cancer Science & Therapy. 9(3). 9 indexed citations
10.
Flynn, Rachel Litman, Maya Jeitany, Hiroaki Wakimoto, et al.. (2015). Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors. Science. 347(6219). 273–277. 376 indexed citations breakdown →
11.
Jeitany, Maya, José Ramón Pineda, Françoise Hoffschir, et al.. (2014). A preclinical mouse model of glioma with an alternative mechanism of telomere maintenance (ALT). International Journal of Cancer. 136(7). 1546–1558. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aino Murtomäki Breakdown of academic impact, for papers by Coralie Hoareau‐Aveilla Breakdown of academic impact, for papers by Basem S. Goueli Breakdown of academic impact, for papers by Esther van de Kamp Breakdown of academic impact, for papers by Ruban Mangadu Breakdown of academic impact, for papers by Ana Angulo‐Urarte Breakdown of academic impact, for papers by Ryan Ward Breakdown of academic impact, for papers by Stéphanie Courtois-Cox Breakdown of academic impact, for papers by Laura Dupont Breakdown of academic impact, for papers by Antonio Díaz‐López
Rankless by CCL
2026